RECRUITINGINTERVENTIONAL

Postoperative Rotational Dynamics of Three Toric Intraocular Lens Designs

Postoperative Rotational Dynamics of Different Toric Intraocular Lens Designs

About This Trial

This prospective comparative cohort study evaluates and compares postoperative rotational stability and time-course dynamics of three commercially available toric intraocular lenses (TECNIS Toric II \[ZCU\], AcrySof IQ Toric, and AT TORBI 709M) after phacoemulsification cataract surgery. Rotation is quantified by registering postoperative retroillumination photographs to the end-of-surgery baseline using iris/scleral landmarks, with follow-up at postoperative day 1, day 3, week 1, week 2, month 1, and month 3. Associations between rotational outcomes and ocular biometric parameters are analyzed using linear mixed-effects models to inform individualized IOL selection and perioperative management.

Who May Be Eligible (Plain English)

Who May Qualify: - Adults aged 18 years or older with age-related cataract scheduled for phacoemulsification cataract surgery. - Presence of regular corneal astigmatism requiring toric intraocular lens implantation. - Eligible for implantation of one of the three study toric intraocular lenses based on preoperative evaluation. - Ability to understand the study procedures and provide written willing to sign a consent form. Who Should NOT Join This Trial: - History of prior ocular surgery in the study eye. - History of ocular trauma in the study eye. - Irregular corneal astigmatism or corneal pathology affecting reliable biometric measurement. - Intraoperative complications, including anterior capsular tear or posterior capsular rupture. - Inadequate pupillary dilation during surgery or postoperative examinations. - Evidence of zonular weakness, zonular dialysis, or lens subluxation. - Active ocular infection or inflammation. - Any other ocular or systemic condition judged by the investigator to potentially affect intraocular lens stability or study outcomes. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Adults aged 18 years or older with age-related cataract scheduled for phacoemulsification cataract surgery. * Presence of regular corneal astigmatism requiring toric intraocular lens implantation. * Eligible for implantation of one of the three study toric intraocular lenses based on preoperative evaluation. * Ability to understand the study procedures and provide written informed consent. Exclusion Criteria: * History of prior ocular surgery in the study eye. * History of ocular trauma in the study eye. * Irregular corneal astigmatism or corneal pathology affecting reliable biometric measurement. * Intraoperative complications, including anterior capsular tear or posterior capsular rupture. * Inadequate pupillary dilation during surgery or postoperative examinations. * Evidence of zonular weakness, zonular dialysis, or lens subluxation. * Active ocular infection or inflammation. * Any other ocular or systemic condition judged by the investigator to potentially affect intraocular lens stability or study outcomes.

Treatments Being Tested

DEVICE

TECNIS Toric II (ZCU)

Using TECNIS Toric II (ZCU) intraocular lens during standard phacoemulsification cataract surgery.

DEVICE

AcrySof IQ Toric

Using AcrySof IQ Toric intraocular lens during standard phacoemulsification cataract surgery.

DEVICE

AT TORBI 709M

Using the AT TORBI 709M intraocular lens during standard phacoemulsification cataract surgery.

Locations (1)

Eye and ENT hospital of Fudan University

Shanghai, Shanghai Municipality, China